Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ALUR

Allurion Technologies (ALUR)

Allurion Technologies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ALUR
DatumZeitQuelleÜberschriftSymbolFirma
11/06/202414h00Business WireAllurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric SurgeryNYSE:ALURAllurion Technologies Inc
06/06/202400h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
05/06/202414h00Business WireAllurion Announces the Appointment of Ojas A. Buch as Chief Operating OfficerNYSE:ALURAllurion Technologies Inc
30/05/202414h00Business WireAllurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1sNYSE:ALURAllurion Technologies Inc
29/05/202422h05Business WireAllurion to Participate in Two Upcoming Investor Conferences in June 2024NYSE:ALURAllurion Technologies Inc
15/05/202414h00Business WireAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossNYSE:ALURAllurion Technologies Inc
14/05/202422h39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ALURAllurion Technologies Inc
14/05/202414h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ALURAllurion Technologies Inc
14/05/202414h00Business WireAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
08/05/202401h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
07/05/202402h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
02/05/202414h00Business WireAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyNYSE:ALURAllurion Technologies Inc
30/04/202414h30Business WireAllurion Announces Preliminary First Quarter 2024 ResultsNYSE:ALURAllurion Technologies Inc
17/04/202414h31Business WireAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsNYSE:ALURAllurion Technologies Inc
04/04/202414h00Business WireAllurion Expands Virtual Care Suite to the United StatesNYSE:ALURAllurion Technologies Inc
21/03/202413h00Business WireAllurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceNYSE:ALURAllurion Technologies Inc
13/03/202413h30Business WireAllurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:ALURAllurion Technologies Inc
12/03/202413h00Business WireMilena Alberti-Perez Joins Allurion Board of Directors as Audit Committee ChairNYSE:ALURAllurion Technologies Inc
04/03/202414h30Business WireAllurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024NYSE:ALURAllurion Technologies Inc
20/02/202422h05Business WireAllurion to Participate in Cowen’s 44th Annual Health Care ConferenceNYSE:ALURAllurion Technologies Inc
08/02/202414h30Business WireAllurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNYSE:ALURAllurion Technologies Inc
29/01/202414h00Business WireBrendan Gibbons Appointed Chief Legal Officer at Allurion TechnologiesNYSE:ALURAllurion Technologies Inc
23/01/202415h04Business WireSomerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
23/01/202414h15Business WireWorld first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
17/01/202414h00Business WireAllurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic PartnershipsNYSE:ALURAllurion Technologies Inc
11/01/202414h00Business WireAllurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-MorbiditiesNYSE:ALURAllurion Technologies Inc
08/01/202414h00Business WireAllurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 OutlookNYSE:ALURAllurion Technologies Inc
05/01/202414h00Business WireNew research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion ProgramNYSE:ALURAllurion Technologies Inc
02/01/202414h00Business WireAllurion’s Digital Platform Gains Traction with Expanded Strategic PartnershipNYSE:ALURAllurion Technologies Inc
13/11/202314h00Business WireAllurion Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
 Showing the most relevant articles for your search:NYSE:ALUR